These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Extranodal natural killer/T-cell lymphoma, nasal type: clinical and computed tomography findings in the head and neck region. Hung LY; Chang PH; Lee TJ; Hsu YP; Chen YW; Fu CH; Huang CC Laryngoscope; 2012 Dec; 122(12):2632-9. PubMed ID: 22965840 [TBL] [Abstract][Full Text] [Related]
23. [Prognostic factors of nasal NK/T-cell lymphoma]. Ma Q; Zhang HL; Liu X; Zhou SY; Qian ZZ; Zhai QL; Fu K; Wang HQ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Dec; 48(12):1011-6. PubMed ID: 24507001 [TBL] [Abstract][Full Text] [Related]
25. Nasal endoscopic evaluation and its impact on survival in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type. Cho HJ; Jang MS; Hong SD; Kim SJ; Ahn YC; Oh D; Ko YH; Kim HY; Dhong HJ; Chung SK; Kim WS Int Forum Allergy Rhinol; 2015 Oct; 5(10):960-6. PubMed ID: 26039707 [TBL] [Abstract][Full Text] [Related]
26. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection. Feng YF; Wu QL; Zong YS Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313 [TBL] [Abstract][Full Text] [Related]
28. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases]. Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682 [TBL] [Abstract][Full Text] [Related]
30. The simultaneous appearance of a nasal natural killer-cell lymphoma and acute myelogenous leukemia. Van Crombrugge L; De Vos G; Vanclooster C; Lemmerling M; Kerre T B-ENT; 2012; 8(1):49-52. PubMed ID: 22545391 [TBL] [Abstract][Full Text] [Related]
31. Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract. Huang MJ; Jiang Y; Liu WP; Li ZP; Li M; Zhou L; Xu Y; Yu CH; Li Q; Peng F; Liu JY; Luo F; Lu Y Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):166-74. PubMed ID: 17919841 [TBL] [Abstract][Full Text] [Related]
32. NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type. Liu X; Wang B; Ma X; Guo Y Jpn J Clin Oncol; 2009 Jul; 39(7):418-24. PubMed ID: 19395464 [TBL] [Abstract][Full Text] [Related]
33. [Clinicopathological analysis of 23 cases of NK/T-cell lymphoma of nasal type]. Lu M; Li F; Hou Q Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan; 23(2):57-60. PubMed ID: 19452707 [TBL] [Abstract][Full Text] [Related]
34. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma]. Yong W; Zheng W; Zhang Y Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):773-5. PubMed ID: 11798962 [TBL] [Abstract][Full Text] [Related]
36. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy. Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611 [TBL] [Abstract][Full Text] [Related]
37. Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type. Liang R Br J Haematol; 2009 Oct; 147(1):13-21. PubMed ID: 19604234 [TBL] [Abstract][Full Text] [Related]